+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Proton radiation therapy for lung cancer: is there enough evidence?



Proton radiation therapy for lung cancer: is there enough evidence?



Oncology 24(11): 1052-1057



Proton radiation for cancer offers the ability to conform the high-dose region of radiation therapy to the tumor while reducing the dose of radiation to adjacent normal tissues. In lung cancer, this equates to greater sparing of uninvolved lung, heart, esophagus, and spinal cord. Sparing these normal tissues permits the delivery of higher-radiation doses to the tumor. Studies that compare the distribution of radiation doses for lung cancer show that proton radiation is superior, even when factors such as respiratory motion are considered. Clinical experience confirms the feasibility of proton radiation for early-stage non-small-cell lung cancers, and clinical trials are being conducted in locally advanced tumors: To date, evidence indicates that proton radiation should be further explored.

(PDF emailed within 1 workday: $29.90)

Accession: 055260434

Download citation: RISBibTeXText

PMID: 21155458


Related references

Proton radiation therapy offers reduced normal lung and bone marrow exposure for patients receiving dose-escalated radiation therapy for unresectable stage iii non-small-cell lung cancer: a dosimetric study. Clinical Lung Cancer 12(4): 252-257, 2011

First Clinical Report of Proton Beam Therapy Versus Intensity Modulated Radiation Therapy for Postoperative Radiation Therapy for Non-Small Cell Lung Cancer. International Journal of Radiation Oncology*biology*physics 93(3): E422-E423, 2015

Advances in radiotherapy techniques and delivery for non-small cell lung cancer: benefits of intensity-modulated radiation therapy, proton therapy, and stereotactic body radiation therapy. Translational Lung Cancer Research 6(2): 131-147, 2017

Advanced radiation techniques for locally advanced non-small cell lung cancer: intensity-modulated radiation therapy and proton therapy. Journal of Thoracic Disease 10(Suppl 21): S2474-S2491, 2018

Intensity-modulated proton therapy reduces the dose to normal tissue compared with intensity-modulated radiation therapy or passive scattering proton therapy and enables individualized radical radiotherapy for extensive stage IIIB non-small-cell lung cancer: a virtual clinical study. International Journal of Radiation Oncology, Biology, Physics 77(2): 357-366, 2010

Proton therapy for post-operative radiation therapy of non-small cell lung cancer. Translational Lung Cancer Research 7(2): 205-209, 2018

Current status of radiation therapy Evidence-based Medicine of radiation therapy Non-small cell lung cancer. Nippon Acta Radiologica 62(5): 188-193, 2002

Current status of radiation therapy: Evidence-based Medicine (EBM) of radiation therapy: Limited stage small cell lung cancer. Nippon Acta Radiologica 62(5): 194-197, 2002

Predictors of high-grade esophagitis after definitive three-dimensional conformal therapy, intensity-modulated radiation therapy, or proton beam therapy for non-small cell lung cancer. International Journal of Radiation Oncology, Biology, Physics 84(4): 1010-1016, 2013

Reirradiation With Proton Beam Therapy or Intensity Modulated Radiation Therapy for Non-small Cell Lung Cancer: An Institutional Experience. International Journal of Radiation Oncology*biology*physics 84(3): S608-S609, 2012

Dosimetric comparison between proton beam therapy and photon radiation therapy for locally advanced non-small cell lung cancer. Japanese Journal of Clinical Oncology 2016, 2016

National Cancer Database Analysis of Proton Versus Photon Radiation Therapy in Non-Small Cell Lung Cancer. International Journal of Radiation Oncology, Biology, Physics 97(1): 128-137, 2017

Lung Dosimetry, Radiation Pneumonitis, and FDG Uptake in Patients With Stage II-III Non-Small Cell Lung Cancer Treated With Passively Scattered Proton Therapy or Intensity Modulated Pho. International Journal of Radiation Oncology*biology*physics 96(2): E455-E456, 2016

Clinical Comparison of Proton Beam Therapy and Stereotactic Body Radiation Therapy for Medically Inoperable Stage I Non-small Cell Lung Cancer. International Journal of Radiation Oncology*biology*physics 84(3): S573-S574, 2012

The potential of proton beam radiation therapy in lung cancer (including mesothelioma). Acta Oncologica 44(8): 881-883, 2005